Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Amortization of Deferred Charges: 2018-2019

Historic Amortization of Deferred Charges for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Dec 2019 value amounting to $600,000.

  • EyePoint Pharmaceuticals' Amortization of Deferred Charges rose 1276.47% to $600,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $843,000, marking a year-over-year change of. This contributed to the annual value of $628,000 for FY2021, which is 35.72% down from last year.
  • According to the latest figures from Q4 2019, EyePoint Pharmaceuticals' Amortization of Deferred Charges is $600,000, which was up 328.57% from $140,000 recorded in Q1 2019.
  • In the past 5 years, EyePoint Pharmaceuticals' Amortization of Deferred Charges ranged from a high of $600,000 in Q4 2019 and a low of -$51,000 during Q4 2018.
  • Moreover, its 2-year median value for Amortization of Deferred Charges was $154,000 (2018), whereas its average is $210,400.
  • Data for EyePoint Pharmaceuticals' Amortization of Deferred Charges shows a peak YoY soared of 1,276.47% (in 2019) over the last 5 years.
  • Over the past 2 years, EyePoint Pharmaceuticals' Amortization of Deferred Charges (Quarterly) stood at -$51,000 in 2018, then soared by 1,276.47% to $600,000 in 2019.
  • Its last three reported values are $600,000 in Q4 2019, $140,000 for Q1 2019, and -$51,000 during Q4 2018.